Bookmark and Share

ACLASTA Drug Information Page

Updated 08/09/2010 12:50:37 AM

ProductSourceDateLinkData
ACLASTAMHRA2010-3-30ACLASTA-MHRA-2010-3-30MHRA Drug Updates: Yasmin: update on risk of venous thromboembolism Clopidogrel and proton pump inhibitors: interaction - updated advice Intravenous zoledronic acid: adverse effects on renal function Parenteral amphotericin B: fatal overdose risk due to confusion between lipid-based and non-lipid-based formulations Rifadin infusion (rifampicin): new solvent formulation and changes to compatible diluents Becaplermin (Regranex) for diabetic ulcers: contraindicated in patients with any known current cancer
ACLASTAMHRA2008-7-7ACLASTA-MHRA-2008-7-7MHRA has issued drug updates: Varenicline: suicidal thoughts and behaviour Bisphosphonates: atrial fibrillation Inhaled products that contain corticosteroids Rotigotine patches: new prescribing and storage requirements Enoxaparin (Clexane) contamination: latest information Ergot-derived dopamine agonists: new warnings and contraindications Etoricoxib: new prescribing guidelines Recombinant human erythropoietins: new warning for use

Joining this website will allow you to recieve emails about any pharmaceutial you are interested in or you can search for other pharmaceuticals on this website. Joining should only take 2 minutes.



Image of checkdrugs.com Logo
© Cardan Technologies Inc

This site is presented as an educational source only and you use it at your own risk. The information on this site is not a substitute for a visit with your doctor or pharmacist. Always talk to your doctor before changing medications or dosage, or if you experience any serious side effects.